Chlorambucil

Chlorambucil – Patient Information for Australia

Basic Product Information

Mechanism of Action

For Patients: Chlorambucil is a type of chemotherapy medicine known as an alkylating agent. It works by interfering with the DNA in cancer cells, stopping them from growing and multiplying. This helps to slow or stop the progression of certain blood cancers.

For Specialists: Chlorambucil is a bifunctional alkylating agent of the nitrogen mustard group. It cross-links DNA strands by forming covalent bonds at the N7 position of guanine, inhibiting DNA replication and transcription, resulting in apoptosis, particularly in rapidly dividing lymphoid cells.

Pharmacokinetics

• Absorption: Well absorbed (approx. 70-90%) when taken orally. Peak plasma concentration within 1 hour.
• Metabolism: Rapidly metabolised in the liver, primarily to phenylacetic acid mustard (active metabolite).
• Elimination: Mainly excreted in urine as inactive metabolites.
• Duration of Action: Plasma half-life approximately 1.5 hours, but biological effects may persist much longer.

Use in Everyday Life & Best Practices

Chlorambucil is usually taken as a tablet by mouth, exactly as prescribed by your haematologist or oncologist. Doses and duration will depend heavily on your individual condition and response. Always follow your specialist’s instructions and never change your dose without medical advice.

• Take at around the same time every day for best effect.
• Swallow tablets whole with a glass of water. Do not crush or chew.
• If you miss a dose, contact your doctor or pharmacist for advice.
• Practice good hygiene and avoid close contact with people who are unwell, as this medication can lower your immunity.
• Regular blood tests will be required during therapy.
• Discuss any new symptoms or side effects with your care team promptly.

Dosing: Morning vs Evening

• Morning: Taking chlorambucil in the morning can help reduce the risk of missing a dose and may lessen sleep disturbances caused by possible side effects such as nausea.
• Evening: Evening dosing is not generally preferred but may be advised in rare situations based on your treatment plan.
• Tip: Consistency is important. Choose a dosing time that fits your daily routine and is easy to remember.

Taking with Food or on an Empty Stomach

• Chlorambucil can be taken with or without food. For some people, taking the tablet with food may help reduce stomach upset or nausea, but food may slightly lower absorption.
• If you have sensitive stomach or are prone to nausea, you may prefer to take chlorambucil after a small meal. Traditional Australian breakfast foods such as a piece of toast or cereal are suitable.
• Avoid grapefruit and grapefruit juice as they may affect how some medications are processed by your body.

Interaction Warnings

Indications

Dosing According to Clinical Indications

All doses must be individualised by your doctor, who will monitor your blood counts throughout therapy.

Safety Profile and Side Effects

Like all medicines, chlorambucil can cause side effects. Some are very common, while others are rare but serious. Tell your doctor or pharmacist if you notice anything unusual.

Guidelines for Proper Use

• Only use chlorambucil as prescribed by your Australian oncologist or haematologist.
• Attend blood test appointments faithfully; your dose may be changed if side effects occur.
• If you are planning dental work or surgery, inform your surgeon you are taking chlorambucil.
• Store tablets below 25°C, in the original packaging, out of reach of children; never share medicines.
• Use an effective contraception method during treatment and for at least 6 months after stopping therapy.
• Seek medical advice if you develop fever, unexplained bruising/bleeding, mouth ulcers, or rash.

Alternative Treatment Options

• Bendamustine: Newer alkylating agent, similar indications; given IV, reimbursed by PBS for some conditions; often preferred for CLL and lymphoma in 2024; fewer long-term side effects, requires hospital visits.
• Fludarabine: Oral/IV agent, effective in CLL; more immunosuppressive, but sometimes used when chlorambucil is ineffective or not tolerated.
• Bortezomib, Rituximab: Targeted therapies; higher cost but greater efficacy for certain lymphoma/leukaemia types; often combined with other agents; access via PBS for specific diagnoses.
• Prednisolone/Corticosteroids: Sometimes used with chlorambucil to boost effect, not suitable alone for aggressive cancers.
• Observation or "watch-and-wait": Selected gentle CLL and follicular lymphoma cases, especially elderly or frail patients.

Comparative Overview: Newer medicines (e.g., bendamustine, targeted monoclonal antibodies) frequently offer better disease control and less risk of long-term complications, but are more expensive and may involve more hospital/clinic time. Chlorambucil remains an option for stable older adults, rural/remote care, or resource-limited situations.

Legal, Registration, and Reimbursement Status in Australia

• Regulatory Approval: Registered with the Therapeutic Goods Administration (TGA)
• Sponsor: Aspen Pharmacare Australia Pty Ltd
• Prescribing: Specialist prescription only (oncologist/haematologist); general practitioners rarely initiate
• Schedule: S4 (Prescription Only Medicine under Australian law)
• Reimbursement: Listed on the Pharmaceutical Benefits Scheme (PBS) for approved cancer indications. Requires Authority prescription for PBS subsidy.
• Supply: Community and major hospital pharmacies across Australia, subject to specialist authority.

Latest Research and Clinical Guidance (2022–2025)

• Emerging role for targeted therapies (e.g., rituximab, BTK inhibitors) in CLL, reducing reliance on alkylating agents like chlorambucil, per the Leukaemia Foundation of Australia and Australian Haematology Society (2023–2024 guidelines).
• Chlorambucil remains appropriate for certain elderly or comorbid patients due to oral route and tolerability (Blood Advances, 2024).
• Use in paediatric nephrotic syndrome is decreasing due to concerns over fertility and malignancy risk, with newer immunosuppressives preferred (Kidney International Reports, 2023).
• References:
  • Roberts AW et al. "CLL guideline update." Blood Adv 2024;8(12):2233–2241.
  • Rogers K, "Leukeran in elderly CLL: role and alternatives," Med J Aust, 2023.
  • Therapeutic Guidelines: eTG complete – Haematology, latest online update 2024.

Availability and Delivery

• Supplied in 25-tablet packs (2 mg tablets).
• Indicative price: $45–$60 per pack (PBS price may be lower for eligible patients).
• Available at major pharmacies, hospital dispensaries, and via prescription home delivery services.

Note: Actual times and availability may vary; please contact your pharmacy for accurate advice.

Frequently Asked Questions (FAQ)

1. Can I continue working while taking chlorambucil?
   Many people continue to work, but you may feel tired or more prone to infection. Speak with your employer about flexible work arrangements if you undergo regular blood tests or feel unwell.
2. Is it safe to get vaccinated during chlorambucil treatment?
   While "inactivated" (non-live) vaccines like COVID-19 or influenza are generally safe, "live" vaccines should be avoided. Always check with your GP, haematologist, or immunisation nurse before any vaccinations.
3. What should I do if I miss a dose?
   Take the missed dose as soon as you remember if it is close to your regular time. If you are unsure or it is nearly time for the next dose, skip the missed dose and resume your schedule. Never double-dose. Call your pharmacist or doctor if in doubt.
4. Will chlorambucil affect my fertility or ability to have children?
   Yes, chlorambucil can cause infertility in both men and women, which may be permanent. Discuss fertility preservation options with your doctor before starting treatment if you wish to have children in the future.
5. Can I drive or use machinery during treatment?
   Chlorambucil may cause dizziness or tiredness. Do not drive or operate machinery if you feel unwell or your concentration is affected.